Sign-up for our newsletter
Protocols & Methods
Reagents & Resources
IMPC / KOMP Data
Dr. Aruna Sarma
Chief & Professor, Dow Division of Health Services Research, Department of Urology, Michigan Medicine. Dr. Sarma has published extensively on the epidemiology of urological complications using epidemiologic and clinical datasets.
Sexual Function and Neuropathy in Pre-Diabetes and Type 2 Diabetes
A common health problem among both men and women, sexual dysfunction increases with advancing age and markedly reduces quality of life (QOL). Our team’s findings from people with type 1 diabetes (T1DM) in the Epidemiology of Diabetes, Interventions and Complications (EDIC) study–the observational extension of the Diabetes Control and Complications Trial (DCCT)–showed that 45% of men reported erectile dysfunction (ED) and 42% of women reported female sexual dysfunction (FSD). Poor glycemic control and cardiac autonomic neuropathy significantly increased risk of ED and FSD in this cohort. Although our findings in EDIC have begun to shed light on the role of prevalent T1DM on sexual dysfunction, data defining the burden, and risk reduction strategies among people who are at risk for type 2 diabetes (T2DM) are limited. The Diabetes Prevention Program (DPP), a randomized controlled trial of overweight and obese men and women at high risk for T2DM, and its observational follow up, the Diabetes Prevention Program Observational Study (DPPOS) now in its 18th year, demonstrated that intense lifestyle intervention and metformin both delayed the onset and progression of T2DM and its complications. At year 15, DPPOS participants completed the International Index of Erectile Function (IIEF) and Female Sexual Function Index (FSFI) yielding validated measures of sexual dysfunction for both genders. We hypothesize that sexual dysfunction in men and women with prediabetes and T2DM is highly prevalent and less favorable trajectories of glycemia and neuropathy predict those at highest risk. Accordingly, we propose to utilize existing data from DPPOS to test these hypotheses. By fully leveraging data in an existing, NIH-funded study, we avoid costs associated with primary data collection and facilitate generation of new knowledge that (1) builds on a growing body of research on the urological complications of DM and (2) has been defined as a high priority to the NIH and other stakeholders.
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!